Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
Trending
- ACF trains Gella residents on climate-smart agriculture
- Kwara NMA calls for stronger healthcare reforms
- Energy expert calls for Nigeria to emulate India’s power reforms
- Experts urge FG to harness Nigeria’s AI ranking for jobs, growth
- PFIPC: BMO rejects claim that Buhari administration created ‘fake agency’
- CBN’s liquidity squeeze leaves banking system with N2.6tn cash inflows, by Chinwe Michael
- Why naira is holding firm despite a stronger US dollar, by Hope Moses-Ashike
- 2027 Presidency: Why we adopted Tinubu — Adeleke
